stockrow
Monday 9 November 2026
Export ETRA’s income statement to Excel — free account
Electra Therapeutics Inc.
ETRA
8.50
0.70
+8.97%
Follow ETRA
Alert me
Electra Therapeutics Inc. (ETRA) P/E ratio
P/E ratio, daily
Annual newest first
| Period | P/E ratio | Change |
|---|
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| RGNX REGENXBIO Inc. compare | n/m |
| CTMX CytomX Therapeutics, Inc. compare | n/m |
| MNPR Monopar Therapeutics Inc. compare | n/m |
| INDP Indaptus Therapeutics, Inc. compare | n/m |
| STTK Shattuck Labs, Inc. compare | n/m |
| CBIO Crescent Biopharma, Inc. compare | n/m |
| MDXG MiMedx Group, Inc compare | n/m |
| DMAC DiaMedica Therapeutics, Inc. compare | n/m |
| ETRA Electra Therapeutics Inc. | — |
| Biotechnology industry median | 10.6× |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)